Iridex Corporation (IRIX) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Iridex Corporation (IRIX:NASDAQ), powered by AI.

Current Price
$1.19
P/E Ratio
-4.5
Market Cap
20M
Sector
Healthcare
What is the Iridex Corporation stock price forecast?

Iridex Corporation is currently trading at $1.19. View real-time AI analysis on Alpha Lenz.

What is Iridex Corporation insider trading activity?

View the latest insider trading data for Iridex Corporation on Alpha Lenz.

What is Iridex Corporation's P/E ratio?

Iridex Corporation's P/E ratio is -4.5.

Iridex Corporation

NASDAQ · IRIX
$1.19+0.01(+0.85%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Iridex Corporation's future dividend policy...
Alpha Chat Insight

Iridex Corporation trades at a P/E of -4.5 (undervalued) with modest ROE of -126.4%.

Ask for details

Company Overview

Iridex Corporation is an established entity in the medical technology sector, specifically focusing on the development and distribution of laser systems for the treatment of eye diseases. Known for its innovative solutions in ophthalmology, the company primarily addresses conditions such as glaucoma, diabetic macular edema, and age-related macular degeneration. Its laser delivery systems, including the MicroPulse technology, are designed to offer precision and safety in non-incisional procedures, which are increasingly preferred in modern medical practice. Iridex significantly impacts the healthcare industry by providing cost-effective and efficacious alternatives to conventional surgeries, supporting better patient outcomes and expedited recovery times. With a commitment to advancing eye care technology, Iridex collaborates closely with ophthalmic professionals and research institutions to refine and expand its product offerings. In the financial market, Iridex Corporation plays a vital role by aligning its innovations with the growing demand for minimally invasive treatments, positioning itself as a key player in the therapeutic laser market.

CEOMr. Patrick Mercer
SectorHealthcare
IndustryMedical Devices
Employees93

Company Statistics

FY 2025

Profile

$20.15MMarket Cap
$52.67MRevenue
0.00Shares Out
93Employees

Margins

36.50%Gross
-1.94%EBITDA
-4.88%Operating
-8.32%Pre-Tax
-8.42%Net

Valuation

-4.54P/E
4.09P/B
0.38EV/Sales
-18.22EV/EBITDA
-8.92P/FCF

Growth (CAGR)

-2.58%Rev 3Yr
7.70%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-15.23%ROA
-126.43%ROE
-8.82%ROIC

Financial Health

$6.03MCash & Cash Equivalents
$18.20MNet Debt
492.26%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Iridex Corporation (ticker: IRIX) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 93 employees. Market cap is $20M.

The current price is $1.19 with a P/E ratio of -4.54x and P/B of 4.09x.

ROE is -126.43% and operating margin is -4.88%. Annual revenue is $53M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Iridex Corporation (IRIX) Stock Forecast 2026 $1.19 — Price, Financials & Analyst Targets | Alpha Lenz